Skip to content
HUB Organoids
services
model and assay development
drug development services
technology
company
about us
events
latest news
careers
resources
license program
contact
Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
eLife | Nov 2016
X
Have any questions?
